Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Heterozygous NKX2-1 loss-of-function variants cause combinations of hyperkinetic movement disorders (MDs, particularly childhood-onset chorea), pulmonary dysfunction, and hypothyroidism. Mobile element insertions (MEIs) are potential disease-causing structural variants whose detection in routine diagnostics remains challenging.
Objective: To establish the molecular diagnosis of two first-degree relatives with clinically suspected NKX2-1-related disorder who had negative NKX2-1 Sanger (SS), whole-exome (WES), and whole-genome (WGS) sequencing.
Methods: The proband's WES was analyzed for MEIs. A candidate MEI in NKX2-1 underwent optimized SS after plasmid cloning. Functional studies exploring NKX2-1 haploinsufficiency at RNA and protein levels were performed.
Results: A 347-bp AluYa5 insertion with a 65-bp poly-A tail followed by a 16-bp duplication of the pre-insertion wild-type sequence in exon 3 of NKX2-1 (ENST00000354822.7:c.556_557insAlu541_556dup) segregated with the disease phenotype.
Conclusions: We identified a de novo exonic AluYa5 insertion causing NKX2-1-related disorder in SS/WES/WGS-negative cases, suggesting that MEI analysis of short-read sequencing data or targeted long-read sequencing could unmask the molecular diagnosis of unsolved MD cases. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/mds.29280 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Respiratory and other organ manifestations in -related disorders: a systematic review.
Front Med (Lausanne)
May 2025
Movement Disorders Unit, Department of Child Neurology, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Background: -related disorders (-RD) encompass a spectrum of conditions arising from pathogenic deletions or variants in the gene, crucial for thyroid, lung, and brain development. Respiratory manifestations in -RD range from neonatal respiratory distress to severe lung diseases, constituting a leading cause of mortality. This study will review and synthesize NKX2-1-RD respiratory phenotypes, genetic alterations, and long-term trajectories.
View Article and Find Full Text PDFSystematic review of thyroid function in NKX2-1-related disorders: Treatment and follow-up.
PLoS One
March 2025
Department of Child Neurology, Movement Disorders Unit, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Article Synopsis
- NKX2-1 is a critical transcription factor linked to rare disorders that cause thyroid, lung, and brain issues, with early diagnosis being key for effective treatment.
- This systematic review analyzes the effectiveness of Levothyroxine (LT4) treatment for NKX2-1-related disorders, focusing on congenital hypothyroidism, treatment initiation, and dosage variations.
- Findings reveal that congenital hypothyroidism is common in these patients, yet LT4 is initiated in only 10%, with significant reliance on age at diagnosis affecting treatment outcomes.
Genetic Analyses in a Cohort of Pediatric Patients with Congenital Hypothyroidism Based on Congenital Hypothyroidism Consensus Guideline.
Horm Res Paediatr
October 2024
Department of Pediatric Endocrinology, Erzurum City Hospital, University of Health Sciences, Erzurum, Turkey.
Article Synopsis
- The study focused on congenital hypothyroidism (CH) and aimed to analyze the clinical and genetic factors associated with it, specifically targeting genetic variants linked to thyroid tissue formation and hormone secretion.
- A total of 61 Turkish patients from 45 families participated, with a variant detection rate of 37.7%; the most common mutations were found in the TPO gene, followed by TSHR, DUOX2, TG, and NKX2-1 genes.
- The research identified rare new gene variations related to CH, suggesting that the current guidelines for genetic analysis are effective, and highlighting the potential prevalence of TSHR mutations in thyroid dysgenesis cases.
Systematic review of thyroid function in NKX2-1-related disorders: Screening and diagnosis.
PLoS One
July 2024
Department of Child Neurology, Movement Disorders Unit, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.
Article Synopsis
- * A systematic review analyzed 1012 studies, ultimately including 46 that focused on screening and diagnosing endocrine issues related to NKX2-1-RD in patients, revealing that 45% had congenital hypothyroidism.
- * The findings indicated inconsistent diagnostic practices, with a significant number of patients diagnosed in adulthood and a need for standardized screening and diagnostic procedures for better management of endocrine disorders associated with NKX2-1-RD.
Insights from European Reference Network for rare neurological disorders study surveys on diagnosis, treatment, and management of NKX2-1-related disorders.
Eur J Paediatr Neurol
July 2024
Department of Paediatric Neurology, Hospital Sant Joan de Déu, Barcelona, Spain; Centre for Rare Diseases and Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen, Calwerstr. 7, 72076, Tübingen, Germany; U-703 Centre for Biomedical Research on Rare Diseases (CIBER-ER),
Background: NKX2-1-related disorder (NKX2-1-RD) is a rare disease characterized by a triad of primary hypothyroidism, neonatal respiratory distress, and neurological features, including chorea.
Objective: This study aimed to identify discrepancies in the management of NKX2-1-RD among European Union (EU) specialists.
Methods: The ERN-RND Chorea & Huntington disease group designed a survey to conduct a cross-sectional multicenter study on the management of NKX2-1-RD.